Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia (CLL): Argentinian Experience"

NCT04016636 is registered in ClinicalTrials.gov with Mela Osorio Maria Jose as lead sponsor.

NCT NCT04016636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04016636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia (CLL): Argentinian Experience"
Lead sponsor
Mela Osorio Maria Jose
Phase
Observational
Overall status
Completed
Start date
August 12, 2019
Completion date
October 15, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cll